Unlock instant, AI-driven research and patent intelligence for your innovation.

Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides

A topical composition, cysteine ​​technology, applied in the direction of peptide preparation methods, chemical instruments and methods, drug combinations, etc., can solve skin damage and other problems

Inactive Publication Date: 2011-01-12
SIGNUM BIOSCIENCES INC
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Continued exposure to in vitro elements can cause skin damage despite the expectation of healthy skin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
  • Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
  • Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides

Examples

Experimental program
Comparison scheme
Effect test

example

[0151] As described in the Examples below, in certain exemplary embodiments, peptides and formulations of the peptides are prepared according to the following general procedures. It should be appreciated that while the general methods describe the synthesis of certain peptides and formulations of the invention, the following general methods and others known to those of ordinary skill in the art can be applied to each of the peptides and formulations disclosed herein By.

example 1

[0153] Method for preparing lipidated peptides

[0154] Protein extracts (100 mL, 5 mg / ml) were mixed with trypsin (100 mL, 0.1 mg / ml) or other endopeptidases (0.1 mg / ml) and incubated at 37°C for 2 hours. The extract was further digested by exopeptidase (100 mL, 0.1 mg / ml). After digestion, the free amino groups of the hydrolyzed protein (about 4.6 mmol) were stirred with acetic anhydride (10 mL) in buffer solution overnight at room temperature. The protected peptide was converted to 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) (1.79 g, 4.6 millimoles) of the activated ester. The active peptide was reacted with lipidated cysteine ​​residues (such as farnesyl-S-cysteine, phytyl- S-cysteine, or geranylgeranyl-S-cysteine) (4.6 mmol) was coupled overnight, yielding 1.0 g to 1.8 g of the desired mixture of homogeneously lipid-modified peptides .

example 2

[0156] Method for preparing lipidated peptides

[0157] Protein extracts (100 mL, 5 mg / ml) were mixed with trypsin (100 mL, 0.1 mg / ml) or other endopeptidases (0.1 mg / ml) and incubated at 37°C for 2 hours. The resulting hydrolyzed peptide mixture was treated with DTT (770 mg, 4.6 mmol) overnight at room temperature to reduce the disulfide bonds. Methods such as reaction with Ellman's reagent (DTNB, 5,5'-dithiobis-(2-nitrobenzoic acid)) are used to measure the free thiol content in a sample of material. A sample (1 ml) of the hydrolyzed protein extract was dissolved in 0.1 M potassium phosphate buffer (pH 7.4) and mixed with 20 mM DTNB solution (50 μL) in the same buffer. Absorbance was observed at 412 nm and 30°C. DTNB reagent reacts with free thiols to release 2-nitro-5-thiobenzoic acid (TNB) (1 equiv), which has a molar extinction coefficient of 14,150 M at 30 °C -1 cm -1 (The concentration of TNB is equal to the concentration of thiol groups in the protein sample). The...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Described are compositions for topical application to keratinous tissues or substrates such as skin, or mucosal surfaces. The composition may be used to treat a skin condition or disease. The composition comprises at least one polypeptide and / or lipidated peptide and a carrier.

Description

[0001] Related applications [0002] This application claims priority over US Provisional Patent Application Serial No. 61 / 067,161, filed February 25, 2008, the entire disclosure of which is incorporated herein by reference. Background technique [0003] While healthy skin is desired, continued exposure to in vitro elements can cause skin damage. The damage can be caused by injury, photodamage, atrophy, dry skin, and the like. Currently, many lotions and creams on the market are designed to help reduce skin damage and / or associated discomfort. There is a constant industry effort to discover novel agents that can treat and reduce skin damage. Contents of the invention [0004] Accordingly, a first aspect of the present invention relates to an isolated peptide or mixture of peptides having lipidated cysteine ​​residues, wherein the lipid is a polyisoprene, and to a peptide comprising said peptide or mixture thereof and a product suitable for topical administration. The com...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K5/00
CPCA61K9/006A61Q19/007A61K9/127A61K8/64C07K1/1077A61K9/0014A61K9/7023A61P17/00A61P17/04A61P17/10A61P17/12A61P23/00A61P29/00A61P3/02A61P31/00A61P31/10A61P31/12A61P33/02A61P39/00A61P39/06
Inventor 李圣烨爱德华多·佩雷斯戈帕尔·萨尔加达兰杰弗里·B·斯托克马克斯韦尔·斯托克迈克尔·沃龙科夫彼得·沃兰宁
Owner SIGNUM BIOSCIENCES INC
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More